LigaChem Biosciences

141080.KQ

105.93 USD

6.10

+6.11%

Overview

Last close

105.93 usd

Market cap

3.84B usd

52 week high

105.93 usd

52 week low

35.65 usd

Target price

112.16 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

36.4952

Price/Book Value

9.1606

Enterprise Value

3.51B usd

EV/Revenue

33.313

EV/EBITDA

155.5966

Key financials

Revenue TTM

105.28M usd

Gross Profit TTM

93.66M usd

EBITDA TTM

-5.24M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

502.02M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.